{"id":"https://openalex.org/W1964176367","doi":"https://doi.org/10.1046/j.1471-4159.2001.00154.x","title":"5\u2010HT2A and D2 receptor blockade increases cortical DA release via 5\u2010HT1A receptor activation: a possible mechanism of atypical antipsychotic\u2010induced cortical dopamine release","display_name":"5\u2010HT2A and D2 receptor blockade increases cortical DA release via 5\u2010HT1A receptor activation: a possible mechanism of atypical antipsychotic\u2010induced cortical dopamine release","alternate_titles":[],"publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W1964176367","doi":"https://doi.org/10.1046/j.1471-4159.2001.00154.x","mag":"1964176367","pmid":"https://pubmed.ncbi.nlm.nih.gov/11238736"},"language":"en","primary_location":{"id":"doi:10.1046/j.1471-4159.2001.00154.x","doi":"https://doi.org/10.1046/j.1471-4159.2001.00154.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.2001.00154.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1964176367"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109108282","display_name":"Junji Ichikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Junji Ichikawa","raw_affiliation_strings":["Division of Psychopharmacology, Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. ichikaj@ctrvax.vanderbilt.edu","Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychopharmacology, Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. ichikaj@ctrvax.vanderbilt.edu","institution_ids":["https://openalex.org/I200719446"]},{"raw_affiliation_string":"Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hideo Ishii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hideo Ishii","raw_affiliation_strings":["Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111617959","display_name":"Stefania Bonaccorso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefania Bonaccorso","raw_affiliation_strings":["Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081393345","display_name":"Wiley L. Fowler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wiley L. Fowler","raw_affiliation_strings":["Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013486078","display_name":"Ian A O'Laughlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ian A. O'Laughlin","raw_affiliation_strings":["Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060728653","display_name":"Herbert Y. Meltzer","orcid":"https://orcid.org/0000-0003-4901-8845","observed_orcids":["https://orcid.org/0000-0003-4901-8845"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Herbert Y. Meltzer","raw_affiliation_strings":["Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Psychopharmacology, Departments of Psychiatry & Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":16.1218,"has_fulltext":false,"cited_by_count":557,"citation_normalized_percentile":{"value":0.99524699,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"76","issue":"5","first_page":"1521","last_page":"1531"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.5981000065803528,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.3955000042915344,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9580000042915344},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-blockade","display_name":"dopamine D2 receptor blockade","score":0.9710000157356262},{"id":"https://openalex.org/keywords/medial-prefrontal-cortex","display_name":"medial prefrontal cortex","score":0.8989999890327454},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/8-oh-dpat","display_name":"8-OH-DPAT","score":0.7900000214576721},{"id":"https://openalex.org/keywords/way-100635","display_name":"WAY-100635","score":0.9240000247955322},{"id":"https://openalex.org/keywords/m100907","display_name":"M100907","score":0.9409999847412109},{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6447219848632812},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6204168200492859},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.6160176992416382},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5648932456970215},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.5563120245933533},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.52247154712677},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5066843628883362},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.4858974814414978},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.48321735858917236},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4566579759120941},{"id":"https://openalex.org/C2781093953","wikidata":"https://www.wikidata.org/wiki/Q21115043","display_name":"5-HT1A receptor","level":5,"score":0.445454865694046},{"id":"https://openalex.org/C2781195155","wikidata":"https://www.wikidata.org/wiki/Q18680","display_name":"Prefrontal cortex","level":3,"score":0.4189659655094147},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4038572907447815},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.39038413763046265},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.37545889616012573},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.29111331701278687},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.27942198514938354},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.2709534168243408},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.23634424805641174},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2167152464389801},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.20119112730026245},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.14883410930633545},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.058165282011032104},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.05315291881561279},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000662","descriptor_name":"Amphetamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002540","descriptor_name":"Cerebral Cortex","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017371","descriptor_name":"8-Hydroxy-2-(di-n-propylamino)tetralin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D044263","descriptor_name":"Receptors, Serotonin, 5-HT1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044402","descriptor_name":"Receptor, Serotonin, 5-HT2A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065127","descriptor_name":"Dopamine D2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1471-4159.2001.00154.x","doi":"https://doi.org/10.1046/j.1471-4159.2001.00154.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.2001.00154.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:11238736","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11238736","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W1847894837","https://openalex.org/W1896218642","https://openalex.org/W1946515464","https://openalex.org/W1956321811","https://openalex.org/W1967092126","https://openalex.org/W1970174017","https://openalex.org/W1972075343","https://openalex.org/W1972522199","https://openalex.org/W1974717864","https://openalex.org/W1979700184","https://openalex.org/W1982579212","https://openalex.org/W1985517071","https://openalex.org/W1986964324","https://openalex.org/W1992281684","https://openalex.org/W1994153884","https://openalex.org/W1994999112","https://openalex.org/W2004534434","https://openalex.org/W2016635401","https://openalex.org/W2016983964","https://openalex.org/W2023986042","https://openalex.org/W2027709174","https://openalex.org/W2029746418","https://openalex.org/W2031472570","https://openalex.org/W2033665338","https://openalex.org/W2035632600","https://openalex.org/W2039315683","https://openalex.org/W2039534965","https://openalex.org/W2041492166","https://openalex.org/W2044479523","https://openalex.org/W2045877881","https://openalex.org/W2048327972","https://openalex.org/W2050378039","https://openalex.org/W2050724215","https://openalex.org/W2054231808","https://openalex.org/W2059250402","https://openalex.org/W2065792595","https://openalex.org/W2068026066","https://openalex.org/W2071844775","https://openalex.org/W2079844362","https://openalex.org/W2080784754","https://openalex.org/W2083252023","https://openalex.org/W2084556472","https://openalex.org/W2086177468","https://openalex.org/W2090252372","https://openalex.org/W2090319774","https://openalex.org/W2090404564","https://openalex.org/W2091932588","https://openalex.org/W2102974182","https://openalex.org/W2106352416","https://openalex.org/W2109865728","https://openalex.org/W2126893363","https://openalex.org/W2148608081","https://openalex.org/W2163815564","https://openalex.org/W2168836105","https://openalex.org/W2171584675","https://openalex.org/W2256393228","https://openalex.org/W2280261174","https://openalex.org/W4239438238","https://openalex.org/W4242666285"],"related_works":["https://openalex.org/W2154178968","https://openalex.org/W2028287654","https://openalex.org/W2018890984","https://openalex.org/W2083771286","https://openalex.org/W2039971142","https://openalex.org/W2037409999","https://openalex.org/W4252533789","https://openalex.org/W1497084816","https://openalex.org/W2029819129","https://openalex.org/W2068675034"],"abstract_inverted_index":{"Atypical":[0],"antipsychotic":[1],"drugs":[2],"(APDs),":[3],"all":[4],"of":[5,81,84,99,108,125,153,201,209,224],"which":[6,136,230],"are":[7,185,231],"relatively":[8],"more":[9],"potent":[10],"as":[11,78],"serotonin":[12],"(5-HT)(2A)":[13],"than":[14],"dopamine":[15,32,48,66,121,144,171],"D(2)":[16,87,105,197,232],"antagonists,":[17,233],"may":[18,205,234],"improve":[19],"negative":[20],"symptoms":[21],"and":[22,60,86,111,163,183,196,218,227],"cognitive":[23],"dysfunction":[24],"in":[25,27,68],"schizophrenia,":[26],"part,":[28],"via":[29,74,194],"increasing":[30],"cortical":[31,47],"release.":[33,49,122,145,172],"5-HT(1A)":[34,75,109,116,134,178,203,210,236],"agonism":[35],"has":[36,139],"been":[37],"also":[38,149],"suggested":[39],"to":[40,42,45,118,168,213],"contribute":[41],"the":[43,54,82,97,151,164,191,207],"ability":[44,98,152,208],"increase":[46,65,119,169,214],"The":[50],"present":[51],"study":[52],"tested":[53],"hypothesis":[55],"that":[56,190,222],"clozapine,":[57],"olanzapine,":[58],"risperidone,":[59],"perhaps":[61],"other":[62],"atypical":[63,192],"APDs,":[64,229],"release":[67],"rat":[69],"medial":[70],"prefrontal":[71],"cortex":[72],"(mPFC)":[73],"receptor":[76,198,211],"activation,":[77],"a":[79,92,104,115,133,175],"result":[80],"blockade":[83],"5-HT(2A)":[85,93,195,225],"receptors.":[88],"M100907":[89,126],"(0.1":[90],"mg/kg),":[91,103,114,132,156,159,162],"antagonist,":[94,135],"significantly":[95],"increased":[96],"both":[100],"S:(-)-sulpiride":[101],"(10":[102],"antagonist":[106],"devoid":[107],"affinity,":[110,204],"R:(+)-8-OH-DPAT":[112,165],"(0.05":[113,131],"agonist,":[117,180],"mPFC":[120,143,170,215],"These":[123,187],"effects":[124],"were":[127],"abolished":[128],"by":[129,137],"WAY100635":[130,146],"itself":[138],"no":[140],"effect":[141],"on":[142],"(0.2":[147,166],"mg/kg)":[148,167],"reversed":[150],"clozapine":[154],"(20":[155],"olanzapine":[157,182],"(1":[158,161],"risperidone":[160,184],"Clozapine":[173],"is":[174],"direct":[176],"acting":[177],"partial":[179],"whereas":[181],"not.":[186],"results":[188],"suggest":[189],"APDs":[193],"blockade,":[199],"regardless":[200],"intrinsic":[202],"promote":[206],"stimulation":[212],"DA":[216],"release,":[217],"provide":[219],"additional":[220],"evidence":[221],"coadministration":[223],"antagonists":[226],"typical":[228],"facilitate":[235],"agonist":[237],"activity.":[238]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1964176367","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":19},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":27},{"year":2013,"cited_by_count":21},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
